Jaguar Health Files 8-K with Exhibits
Ticker: JAGX · Form: 8-K · Filed: Apr 28, 2025 · CIK: 1585608
Sentiment: neutral
Topics: disclosure, financial-statements, exhibits
Related Tickers: JAGX
TL;DR
Jaguar Health filed an 8-K on 4/28/25, mostly for financial docs & Reg FD.
AI Summary
On April 28, 2025, Jaguar Health, Inc. filed an 8-K report. The filing primarily concerns financial statements and exhibits, along with a Regulation FD disclosure. No specific financial figures or new material events were detailed in the provided excerpt.
Why It Matters
This filing indicates Jaguar Health is providing updated financial information and disclosures to the SEC, which is standard practice for public companies.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of financial statements and exhibits, not indicating any immediate material changes or risks.
Key Players & Entities
- Jaguar Health, Inc. (company) — Registrant
- April 28, 2025 (date) — Date of Report
- Delaware (jurisdiction) — State of Incorporation
- 200 Pine Street Suite 400 (address) — Principal Executive Offices
- San Francisco, California (location) — Principal Executive Offices City and State
- 415-371-8300 (phone_number) — Registrant's Telephone Number
FAQ
What is the primary purpose of this 8-K filing by Jaguar Health, Inc.?
The filing is primarily for Regulation FD Disclosure and to provide Financial Statements and Exhibits.
On what date was this 8-K report filed?
The report was filed on April 28, 2025.
What is the company's principal executive office address?
The principal executive offices are located at 200 Pine Street Suite 400, San Francisco, California 94104.
What is Jaguar Health, Inc.'s telephone number?
The company's telephone number, including area code, is (415) 371-8300.
In which state was Jaguar Health, Inc. incorporated?
Jaguar Health, Inc. was incorporated in Delaware.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 28, 2025 regarding Jaguar Health, Inc. (JAGX).